Department of Pediatric Surgery, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Department of Plastic and Reconstructive Surgery, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Pediatr Surg Int. 2024 Oct 1;40(1):259. doi: 10.1007/s00383-024-05843-5.
Congenital diaphragmatic hernia (CDH) and cleft lip and/or palate (CL/P) are inborn closure defects. Genetic factors in and outcomes for patients with both anomalies (CDH+CL/P) remain unclear. We aimed to investigate associated genetic aberrations, prevalence of, and outcomes for, CDH+CL/P.
Data from Congenital Diaphragmatic Hernia Study Group (CDHSG) registry were collected. CL/P prevalence in CDH patients was determined. Genetic abnormalities and additional malformations in CDH+CL/P were explored. Patient characteristics and outcomes were compared between CDH+CL/P and isolated CDH (CDH-) using Fisher's Exact Test for categorical, and t-test or Mann-Whitney U-test for continuous, data. p < 0.05 was considered statistically significant.
Genetic anomalies in CDH+CL/P included trisomy 13, 8p23.1 deletion, and Wolf-Hirschhorn syndrome (4p16.3 deletion). CL/P prevalence in CDH was 0.7%. CDH+CL/P had lower survival rates than CDH-, a nearly fourfold risk of death within 7 days, were less supported with extracorporeal life support (ECLS), had higher non-repair rates, and survivors had longer length of hospital stay.
Genetic anomalies, e.g. trisomy 13, 8p23.1 deletion, and Wolf-Hirschhorn syndrome, are seen in patients with the combination of CDH and orofacial clefts. CL/P in CDH patients is rare and associated with poorer outcomes compared to CDH-, influenced by goals of care decision-making.
先天性膈疝(CDH)和唇裂和/或腭裂(CL/P)是先天性的闭合缺陷。患有这两种异常的患者的遗传因素和结果仍不清楚。我们旨在研究相关的遗传异常、CDH+CL/P 的患病率和结果。
收集先天性膈疝研究组(CDHSG)登记处的数据。确定 CDH 患者中 CL/P 的患病率。探讨 CDH+CL/P 中的遗传异常和其他畸形。使用 Fisher 精确检验比较 CDH+CL/P 和孤立性 CDH(CDH-)之间的患者特征和结果,用于分类数据,t 检验或 Mann-Whitney U 检验用于连续数据。p<0.05 被认为具有统计学意义。
CDH+CL/P 的遗传异常包括三体 13、8p23.1 缺失和 Wolf-Hirschhorn 综合征(4p16.3 缺失)。CDH 中的 CL/P 患病率为 0.7%。CDH+CL/P 的生存率低于 CDH-,7 天内死亡的风险几乎高出四倍,体外生命支持(ECLS)的支持较少,非修复率较高,幸存者的住院时间较长。
在患有 CDH 和口腔裂的患者中可以看到遗传异常,例如三体 13、8p23.1 缺失和 Wolf-Hirschhorn 综合征。CDH 患者中的 CL/P 罕见,与 CDH-相比,预后较差,受治疗目标决策的影响。